Brebion J, Beck C, Descottes B, Olivier J P
Pathol Biol (Paris). 1978 Sep;26(6):361-2.
The studies of the levels of the CEA and of the beta2m were both performed on 52 patients. The authors pointed out the interest of measurement of these 2 markers and above all the interest of their complementary before any therapy and during treatment by surgery or radiotherapy whether associated or not.
对52例患者进行了癌胚抗原(CEA)和β2-微球蛋白(beta2m)水平的研究。作者指出了检测这两种标志物的意义,尤其是在任何治疗之前以及手术或放疗治疗期间(无论是否联合使用),它们互补检测的意义。